A MAJOR pharmaceutical company is in the final stages of moving into the former AstraZeneca site in Loughborough – which is set to employ up to 300 people.
Recycling company Jayplas acquired the 69-acre site in 2012 with a plan to develop the facility into a leading UK science park known as The Charnwood Campus.
This week it has been announced that an overseas pharmaceutical company has acquired the former manufacturing plant, which is a “substantial part of the site.” Jayplas is not in a position to name the company until August, but says the move will see 300 people working from Building 28 and 29.
This will be the first time pharmaceutical lab and manufacturing work has taken place on the site since AstraZeneca, the town’s biggest employer, left at the end of 2011.
Gosia Khrais, commercial and marketing director for Charnwood Campus, told the Echo: “They are 99.9 per cent, unless a proper natural disaster happens at home they will be doing it. This is the only reason to stop them with the deal.
“They will be bringing a core team with them but they will be sourcing people locally.
“They were not able to give a ratio percentage (of people they want) but we know they are not relocating the whole department.”
Mrs Khrais says the pharmaceutical company is “well established”.
And this is not the only news to come from the site. This week, Charnwood Campus announced that computer systems company, Apical, will be moving into Building 31 this August. They will be appointing 80 people, with the potential of up to 120 employees over the next three years.
The campus is also in close contact with another pharmaceutical company for Buildings 47 and 28, which is lab and office space. She says a team of 20 engineers are evaluating the site with the potential of re-commissioning the building. She says the move has the potential of attracting up to 350 employees.
And a local design company has also shown an interest in Building 24. The company is looking for a space by January 2016 with a workforce of 60 to 80 people.
As previously reported, negotiations are still taking place with NHS pathology facility Empath – which aims to bring 350 to 400 people to Building 21 on the site. Empath is a joint venture between Nottingham University Hospitals and the University Hospitals of Leicester NHS Trusts.
The campus says this is likely to take “another year of discussions.”
By Matt Jarram